WiseGuyReports.com adds “Immunoassay Clinical Analyzer Market in the US 2016-2020” to its research database.
This global market research report presents a comprehensive segmentation of the market based on the application (oncology and endocrinology, hepatitis and retrovirus testing, infectious disease testing, GI stool testing, and others) and the product type (instruments and services, and spare parts). The report also provides a market share analysis of the leading companies in this market, including Abbott Diagnostics, Beckman Coulter, bioMerieux, Roche Diagnostics, and Siemens Healthcare.
Market outlook of the immunoassay clinical analyzer market in the US
Technavio’s market research analyst predicts the immunoassay clinical analyzer market in the US to grow at a healthy CAGR of around 6% during the forecast period. The patients’ growing demand for high-throughput screening with the aid of immunoassays is a significant factor that augments growth in this market during the forecast period.
In this market research report, analysts estimate eminent factors, such as the rising demand for next-generation immunodiagnostics, to drive market growth during the forecast period. These immunodiagnostic devices address the needs of modern clinical laboratories and provide high quality, reliable test results for patients and clinicians. The ability of such devices to improve the workflow and turnaround time for tests is envisaged to impel market growth during the forecast period.
Competitive landscape and key vendors
This market is characterized by the presence of intense competition among several large, medium, and small-sized manufacturers. These vendors form partnerships and provide premium-priced products to maintain their market share. However, since the local vendors in this market offer products at lower prices, they can be a serious threat to large companies.
Complete report in Detailed @ https://www.wiseguyreports.com/reports/immunoassay-clinical-analyzer-market-in-the-us-2016-2020
The top vendors in the market are -
- Abbott Diagnostics
- Beckman Coulter
- Roche Diagnostics
- Siemens Healthcare Diagnostic
Other prominent vendors in the market include Affimetrix, Boditech Med, DiaSorin, DRG International, Enzo Life Sciences, EMD Millipore, Immunodiagnostics System, Inova Diagnostics, Meso Scale Discovery, Nova Century Scientific, Olympus, Quidel, Radiometer, Randox Laboratories, SDIX, Tecan, and Thermo Fisher Scientific.
Order a Purchase Report Copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=366379
Application-based segmentation of the immunoassay clinical analyzer market in the US
- Oncology and endocrinology
- Hepatitis and Retrovirus testing
- Infectious disease testing
- GI stool testing
The oncology and endocrinology segment is estimated to be the fastest-growing market segment during the forecast period. This segment is envisaged to exhibit an impressive market growth rate of nearly 7% by 2020, and factors like the high popularity of immunoassay analyzers due to their compact size and cost-efficiency are expected to further impel market growth during the predicted period.
Segmentation by product of the immunoassay clinical analyzer market in the US
- Services and spare parts
In this market research report, analysts have estimated the instruments segment to account for more than 75% of the total market share by 2020. Much of this segment’s growth can be attributed to the high popularity of instruments, such as immunoassay analyzers, in hospitals and clinical laboratories for automated biochemical testing.
P: +44 208 133 9349
M: +1 646 845 9349